Business Segments · Finite-lived intangible assets, net

Developed Markets — Finite-lived intangible assets, net

Viatris Developed Markets — Finite-lived intangible assets, net decreased by 13.7% to $6.63B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 13.7%, from $7.68B to $6.63B. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementSegment
CategoryMarket Position
SignalHigher is better
VolatilityStable
First reportedQ4 2019
Last reportedQ4 2025

How to read this metric

A steady or growing balance suggests ongoing investment in product pipelines, while a rapid decline may indicate asset aging or lack of replacement.

Detailed definition

The net book value of identifiable intangible assets, such as patents, trademarks, and product rights, that have a defin...

Peer comparison

Standard balance sheet item for pharmaceutical companies, often categorized as 'Intangible Assets' or 'Product Rights'.

Metric ID: vtrs_segment_developed_markets_finite_lived_intangible_assets_net

Historical Data

5 periods
 Q4 '21Q4 '22Q4 '23Q4 '24Q4 '25
Value$14.31B$12.21B$9.43B$7.68B$6.63B
QoQ Change-14.7%-22.8%-18.6%-13.7%
YoY Change-14.7%-22.8%-18.6%-13.7%
Range$6.63B$14.31B
CAGR-53.7%
Avg YoY Growth-17.4%
Median YoY Growth-16.6%
Current Streak4+ quarters decline

Frequently Asked Questions

What is Viatris's developed markets — finite-lived intangible assets, net?
Viatris (VTRS) reported developed markets — finite-lived intangible assets, net of $6.63B in Q4 2025.
How has Viatris's developed markets — finite-lived intangible assets, net changed year-over-year?
Viatris's developed markets — finite-lived intangible assets, net decreased by 13.7% year-over-year, from $7.68B to $6.63B.
What does developed markets — finite-lived intangible assets, net mean?
The remaining value of identifiable intangible assets with limited lifespans held in the Developed Markets segment.